Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy
Compared with controls, patients with breast cancer and lymphoma showed persistent cognitive worsening up to 1-year posttreatment, and patients with breast cancer reported perceived impairment at 2 years compared with controls.
Authors
- AnnaLynn M. Williams (ORCID: https://orcid.org/0000-0002-7042-5851)
- Mostafa Mohamed (ORCID: https://orcid.org/0000-0003-2936-5794)
- Benjamin Esparaz
- Timothy B. Winslow
- Kah Poh Loh (ORCID: https://orcid.org/0000-0002-6978-0418)
- Jamal Misleh (ORCID: https://orcid.org/0009-0004-7747-0948)
- Tianming Zhao (ORCID: https://orcid.org/0000-0002-3871-6173)
- Nikesha Gilmore (ORCID: https://orcid.org/0000-0002-5079-1723)
- Allison Magnuson (ORCID: https://orcid.org/0000-0002-0968-8265)
- Michelle C. Janelsins (ORCID: https://orcid.org/0000-0003-2258-7247)
- Chin‐Shang Li (ORCID: https://orcid.org/0000-0002-0054-4476)
- Hongying Sun (ORCID: https://orcid.org/0000-0003-3144-3544)
- Umang Gada (ORCID: https://orcid.org/0009-0006-2303-7318)
- James D. Bearden
- R. Alieldin
- Hannah Teets
Institutions
- University of South Carolina Upstate (US)
- Christiana Care Health System (US)
- Rochester Institute of Technology (US)
- Spartanburg Regional Medical Center (US)
- University of Rochester Medical Center (US)
- Heartland Cancer Research (US)
Publication Details
- Journal
- JNCI Cancer Spectrum
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1093/jncics/pkaf105
- Citations
- 1
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Northwell Health
- National Cancer Institute